(Q39783365)

English

Heterologous prime boost vaccination with DNA and recombinant modified vaccinia virus Ankara protects IFNAR(-/-) mice against lethal bluetongue infection

scientific article published on 24 October 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 September 2017

Heterologous prime boost vaccination with DNA and recombinant modified vaccinia virus Ankara protects IFNAR(-/-) mice against lethal bluetongue infection (English)

1 reference

Europe PubMed Central

14 September 2017

bluetongue virus

0 references

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

author name string

Eva Calvo-Pinilla

1

1 reference

Europe PubMed Central

14 September 2017

Teresa Rodríguez-Calvo

2

1 reference

Europe PubMed Central

14 September 2017

Noemí Sevilla

3

1 reference

Europe PubMed Central

14 September 2017

Javier Ortego

4

1 reference

Europe PubMed Central

14 September 2017

language of work or name

0 references

publication date

24 October 2009

1 reference

Europe PubMed Central

14 September 2017

1 reference

Europe PubMed Central

14 September 2017

28

1 reference

Europe PubMed Central

14 September 2017

2

1 reference

Europe PubMed Central

14 September 2017

437-445

1 reference

Europe PubMed Central

14 September 2017

The epidemiology of bluetongue

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Bluetongue in northern Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Assignment of the genome segments of bluetongue virus type 1 to the proteins which they encode.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Bluetongue virus entry into cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Genetic characterization of toggenburg orbivirus, a new bluetongue virus, from goats, Switzerland

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Analysis and phylogenetic comparisons of full-length VP2 genes of the 24 bluetongue virus serotypes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Changes in the outer capsid proteins of bluetongue virus serotype ten that abrogate neutralization by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Bluetongue virus proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Prospects for improved bluetongue vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Recombinant capripoxviruses expressing proteins of bluetongue virus: evaluation of immune responses and protection in small ruminants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Role of neutralising antibody in passive immunity to bluetongue infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

The ovine cytotoxic T lymphocyte responses to bluetongue virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Antigen specificity of the ovine cytotoxic T lymphocyte response to bluetongue virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Enhancing DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Efficacy of particle-based DNA delivery for vaccination of sheep against FMDV

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Priming with DNA plasmids encoding the nucleocapsid protein and glycoprotein precursors from Rift Valley fever virus accelerates the immune responses induced by an attenuated vaccine in sheep.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Protective immunity against porcine circovirus 2 in mice induced by a gene-based combination vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Prime-boost immunization with DNA followed by a recombinant vaccinia virus expressing P50 induced protective immunity against Babesia gibsoni infection in dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Establishment of a Bluetongue Virus Infection Model in Mice that Are Deficient in the Alpha/Beta Interferon Receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Functional role of type I and type II interferons in antiviral defense

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Bluetongue virus detection by two real-time RT-qPCRs targeting two different genomic segments.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Vaccines against bluetongue in Europe.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Bluetongue virus: virology, pathogenesis and immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

The non-structural proteins of bluetongue virus are a dominant source of cytotoxic T cell peptide determinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

A DIVA system based on the detection of antibodies to non-structural protein 3 (NS3) of bluetongue virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

Recombinant virus vaccine for bluetongue disease in sheep

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.10.027

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2009.10.027

1 reference

Europe PubMed Central

14 September 2017

1 reference

Europe PubMed Central

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39783365&oldid=2090324803"